Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Clevudine

Generic Name: Clevudine

Drug Type: Small Molecule

Chemical Formula: C_₁₀H_₁₃FN_₂O_₅

CAS Number: 163252-36-6

Unique Ingredient Identifier: IN51MVP5F1

Overview

No overview information available.

Background

No background information available.

Indication

用于慢性乙型肝炎(简称乙肝)的治疗。

Associated Conditions

Viral Hepatitis B

Clinical Trials

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

Phase 2

Completed

Posted: 2021/05/18

Sponsor:

Bukwang Pharmaceutic...

ID:NCT04891302

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

Phase 2

Completed

Posted: 2020/04/15

Sponsor:

Bukwang Pharmaceutic...

ID:NCT04347915

A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients

Phase 4

Terminated

Posted: 2010/12/24

Sponsor:

Bukwang Pharmaceutic...

ID:NCT01266005

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Phase 4

Completed

Posted: 2010/12/21

Sponsor:

Bukwang Pharmaceutic...

ID:NCT01264367

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

Phase 4

Completed

Posted: 2010/12/21

Sponsor:

Bukwang Pharmaceutic...

ID:NCT01264354

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy